Exscientia Is A Technology Driven Drug Design And Development Company Based In Oxfordukfounded In 2012 By Professor Andrew Hopkins And Drtim Guilliamsthe Company Focuses On Revolutionizing The Drug Discovery Process Using Artificial Intelligenceai Machine Learningand Automationexscientia Aims To Create More Effective Medicines For Patients By Combining Precision Design With Integrated Experimentationit Is Recognized For Being The First Company To Advance Ai Designed Small Molecules Into Clinical Trials The Company S Primary Service Is Its Ai Driven Drug Discovery Platformwhich Utilizes Machine Learning Algorithms And Big Data Analytics To Predict And Design Promising Drug Candidatesthis Platform Analyzes Extensive Dataincluding Chemical Structures And Clinical Trial Resultsto Identify Potential Drug Candidates Across Various Therapeutic Areassuch As Oncology And Neurologyexscientia Has Established Partnerships With Leading Pharmaceutical Companiesincluding Merck And Recursionto Enhance Drug Discovery Efforts And Drive Innovation In The Healthcare Industry
No conferences found for this company.
| Company Name | Exscientia Ltd |
| Country |
United Kingdom
|
| Address | N/A |
| Telephone | N/A |
| N/A |
